AGT and hypertensive disorder: IONIS-AGT-LRx, an antisense oligonucleotide (ASO) targeting angiotensinogen (AGT) mRNA, represents a novel therapeutic strategy for hypertension management by inhibiting the RAAS upstream at the hepatic level.